GB:SYNC Stock Latest News
Company AnnouncementsSyncona Boosts OMass Stake as Biotech Raises $310m Series C1M ago
Company AnnouncementsSyncona Portfolio Firm Beacon Shows Strong Pivotal Data in XLRP Gene Therapy1M ago
Company AnnouncementsSyncona reshapes leadership to drive value in maturing life sciences portfolio1M ago
Company AnnouncementsSyncona’s Beacon Therapeutics hits pivotal XLRP trial milestone, marking key value inflection1M ago
Company AnnouncementsSyncona shareholders approve all resolutions at 2026 AGM3M ago
Company AnnouncementsSyncona Highlights Portfolio Progress and Prepares for Key Value Milestones3M ago
Company AnnouncementsSyncona Publishes 2026 Annual Report and Sets August AGM4M ago
Company AnnouncementsSyncona Director Increases Stake with Share Purchase on London Stock Exchange4M ago
Company AnnouncementsSyncona Sets £250m Return Target as Portfolio Advances to Late-Stage Trials5M ago
Company AnnouncementsSyncona appoints veteran investment specialist Norman Crighton to board5M ago
Company AnnouncementsSyncona Wins Shareholder Backing for New Investment Policy and Board Refresh8M agoCompany AnnouncementsSyncona’s Quell Therapeutics Advances Lead CAR-Treg Autoimmune Therapy and Refocuses Pipeline8M ago
Company AnnouncementsSyncona Refines Investment Strategy and Incentives Ahead of Shareholder Vote9M ago
Company AnnouncementsSyncona Posts Strong Q3 NAV Gains as Beacon Financing and Late‑Stage Pipeline Drive Outlook9M ago
Company AnnouncementsSyncona Ups Beacon Therapeutics Stake as Gene Therapy Group Raises $75m Series C10M ago
Company AnnouncementsSyncona Limited Announces Total Voting Rights Update11M ago
Company AnnouncementsSyncona Limited to Issue New Shares Under Incentive Scheme1y ago
Company AnnouncementsSyncona Limited Reports Interim Results, Positions for Growth in Biotech Sector1y agoCompany AnnouncementsSyncona Highlights Autolus Therapeutics’ Q3 2025 Financial Performance and Strategic Growth1y ago



